Suskind Dennis 4
Research Summary
AI-generated summary
CME Group Director Dennis Suskind Sells 748 Shares
What Happened
- Dennis Suskind, a director of CME Group Inc. (CME), sold 748 shares in an open-market/private sale on February 6, 2026. The shares were disposed at $300.00 each for a total of $224,400. This was a sale (not a purchase); sales by insiders can be routine and do not by themselves indicate a change in company outlook.
Key Details
- Transaction date and price: Feb 6, 2026 — 748 shares at $300.00 per share.
- Total value: Approximately $224,400.
- Shares owned after transaction: Not specified in the provided filing summary.
- Footnotes / plan: No 10b5-1 plan, tax-withholding, or other footnotes were reported in the transaction details provided.
- Filing date/timeliness: Form 4 was filed on Feb 9, 2026 (three days after the transaction); insiders are generally required to file within two business days—review the official filing for any tardiness designation.
Context
- This was a cash sale of existing shares rather than a purchase or option exercise. Sales by non-executive directors are often for diversification or personal reasons; they do not on their own signal management’s view of the company’s prospects. Retail investors should consider this data point alongside other insider activity and the company’s fundamentals.